Generation and characterization of potential dengue vaccine candidates based on domain III of the envelope protein and the capsid protein of the four serotypes of dengue virusEdith Suzarte, Lisset Hermida, Ernesto Marcos et al.|Archives of Virology|2014Cited by 34
A Tetravalent Formulation Based on Recombinant Nucleocapsid-like Particles from Dengue Viruses Induces a Functional Immune Response in Mice and MonkeysLázaro Gil, Lisset Hermida, Laura Lazo et al.|The Journal of Immunology|2016Cited by 31
The tetravalent formulation of domain III‐capsid proteins recalls memory B‐ and T‐cell responses induced in monkeys by an experimental dengue virus infectionLázaro Gil, Lisset Hermida, Laura Lazo et al.|Clinical & Translational Immunology|2017Cited by 16
A dose-response study in mice of a tetravalent vaccine candidate composed of domain III-capsid proteins from dengue virusesIris Valdés, Lisset Hermida, Ernesto Marcos et al.|Archives of Virology|2017Cited by 15
A heterologous prime-boost strategy for immunization against Dengue virus combining the Tetra DIIIC subunit vaccine candidate with the TV005 live-attenuated tetravalent vaccineIris Valdés, Lisset Hermida, Alienys Izquierdo et al.|Journal of General Virology|2019Cited by 8